Kara Willenburg, MD
Infectious Disease · Huntington, WVNPI 1972705150
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $152 of the $222 with a category attached, or 68.4%. 4 manufacturers reported payments, led by Astellas Pharma US Inc at 31.6% of the total.
Across 5 payments — averaging $44.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$70
- Merck$60
- Viiv Healthcare Company$54
- Boston Scientific$37
What the payments were for
- Food & beverage$15268%
- Education$7032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 2 | $70 |
| Merck | 1 | $60 |
| Viiv Healthcare Company | 1 | $54 |
| Boston Scientific | 1 | $37 |
How this compares
$222 in reported general payments places this provider in the 75th percentile of 39 infectious disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 17 | $67,578 |
| Cephalexin | 30 | $769 |
| Doxycycline Hyclate | 29 | $584 |
| Fluconazole | 14 | $363 |
| Amoxicillin | 16 | $177 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $167 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $130 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Huntington
- Leeja JosephHuntington$517
- Theresa HysellHuntington$486
- Mahmoud ShormanHuntington$482
- Jennifer HanrahanHuntington$104
- James VaillantHuntington$84
- Hesham AwadhHuntington$49
- Ahmad NusairHuntington$17
- Dino DelaportasBridgeport$478K
- Zonaira GulBeckley$2K
- Archana VasudevanMorgantown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.